www.amgenbd.com
Open in
urlscan Pro
2a02:26f0:3500:18::1724:a293
Public Scan
Submitted URL: http://amgenbd.com/
Effective URL: https://www.amgenbd.com/s/
Submission: On March 05 via api from US — Scanned from DE
Effective URL: https://www.amgenbd.com/s/
Submission: On March 05 via api from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Loading ×Sorry to interrupt CSS Error Refresh Search... Loading... Login * Home * More Loading Business Development * ABOUT US * WORKING TOGETHER * OPPORTUNITIES * NEWS AND EVENTS * CONTACT US * SUBMIT A PROJECT POWERING PARTNERSHIPS THAT IGNITE INNOVATION Amgen Business Development pursues and cultivates partnerships to advance the discovery, development, and delivery of life-changing therapies for patients worldwide. POWERING PARTNERSHIPS THAT IGNITE INNOVATION Amgen Business Development pursues and cultivates partnerships to advance the discovery, development, and delivery of life-changing therapies for patients worldwide. Amgen Business Development is committed to partnering with innovators in the fight against serious illness. We share your passion and take the time to understand your program, so you can have the confidence that your innovation will be developed with the required expertise and dedication. ABOUT US We make the process of bringing innovative therapies to life simpler, more personal, and more expedient. With individualized partnership structures that adapt to your needs and direct access to decision makers, we can get to decisions—and delivering life-improving therapies—sooner. OUR PROCESS AND PARTNERSHIPS We make the process of bringing innovative therapies to life simpler, more personal, and more expedient. With individualized partnership structures that adapt to your needs and direct access to decision makers, we can get to decisions—and delivering life-improving therapies—sooner. OUR PROCESS AND PARTNERSHIPS Amgen is a fully-integrated biotechnology company. From human genetics and target validation capabilities to global commercialization of novel therapeutics, we support the full life-cycle of drug development and can leverage innovation at virtually every stage in the process. OUR CAPABILITIES We are seeking innovation, from early discovery and technologies to late-stage therapeutics, that has the potential to generate meaningful therapies for patients with serious illnesses. Our therapeutic areas include immunology, oncology, bone, nephrology, cardiovascular, and metabolic disorders. AREAS OF OPPORTUNITY We are seeking innovation, from early discovery and technologies to late-stage therapeutics, that has the potential to generate meaningful therapies for patients with serious illnesses. Our therapeutic areas include immunology, oncology, bone, nephrology, cardiovascular, and metabolic disorders. AREAS OF OPPORTUNITY THE IMPACT OF OUR PARTNERSHIPS * BeiGene A strategic collaboration which helps Amgen expand its oncology presence in China, the world’s second-largest pharmaceutical market. LEARN MORE * AstraZeneca AstraZeneca and Amgen combine their mutual strengths to jointly develop and commercialize tezepelumab. LEARN MORE * Vigil Neuroscience/Atlas Venture Amgen out-licensed TREM2 programs to launch a new microglia-focused therapeutics company dedicated to treating neurodegenerative disease. LEARN MORE * Arrowhead Pharmaceuticals A licensing and collaboration agreement accelerates the development of RNA interference therapies for cardiovascular disease. LEARN MORE * Nuevolution A long-term collaboration leads to an acquisition, expanding Amgen’s ability to discover novel small molecules to meet therapeutic objectives. LEARN MORE * BeiGene A strategic collaboration which helps Amgen expand its oncology presence in China, the world’s second-largest pharmaceutical market. LEARN MORE * AstraZeneca AstraZeneca and Amgen combine their mutual strengths to jointly develop and commercialize tezepelumab. LEARN MORE * Vigil Neuroscience/Atlas Venture Amgen out-licensed TREM2 programs to launch a new microglia-focused therapeutics company dedicated to treating neurodegenerative disease. LEARN MORE * BEIGENE A strategic collaboration which helps Amgen expand its oncology presence in China, the world’s second-largest pharmaceutical market. ASTRAZENECA AstraZeneca and Amgen combine their mutual strengths to jointly develop and commercialize tezepelumab. VIGIL NEUROSCIENCE/ATLAS VENTURE Amgen out-licensed TREM2 programs to launch a new microglia-focused therapeutics company dedicated to treating neurodegenerative disease. ARROWHEAD PHARMACEUTICALS A licensing and collaboration agreement accelerates the development of RNA interference therapies for cardiovascular disease. NUEVOLUTION A long-term collaboration leads to an acquisition, expanding Amgen’s ability to discover novel small molecules to meet therapeutic objectives. * A strategic collaboration which helps Amgen expand its oncology presence in China, the world’s second-largest pharmaceutical market. Tab * AstraZeneca and Amgen combine their mutual strengths to jointly develop and commercialize tezepelumab. Tab * Amgen out-licensed TREM2 programs to launch a new microglia-focused therapeutics company dedicated to treating neurodegenerative disease. Tab * A licensing and collaboration agreement accelerates the development of RNA interference therapies for cardiovascular disease. Tab * A long-term collaboration leads to an acquisition, expanding Amgen’s ability to discover novel small molecules to meet therapeutic objectives. Tab More About Amgen BD DOWNLOAD BROCHURE Partner With Us SUBMIT A PROJECT We use cookies and other technologies to personalize content and ads, as well as to provide social media features on this website. By clicking “Accept” you are directing Amgen to disclose your personal information to third parties for the purposes stated above. DECLINE ACCEPT * ABOUT US * * Overview * Functions * Amgen Ventures * Our Team * WORKING TOGETHER * * Overview * Our Process * Deal Structuring * Amgen Pipeline * OPPORTUNITIES * * Overview * Areas of Opportunity * The Amgen Advantage * NEWS AND EVENTS * * News * Events * Featured Stories * CONTACT US * * Submit a Project * Contact Us * SUBMIT A PROJECT -------------------------------------------------------------------------------- * Privacy Statement * Terms of Use * Amgen.com * * © 2014–2021 Amgen Inc. All Rights Reserved. Stay Connected: * * * * * Stay Connected: * * * * * * Privacy Statement * Terms of Use * Amgen.com -------------------------------------------------------------------------------- © 2014–2021 Amgen Inc. All Rights Reserved. Loading